Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements

NCT ID: NCT03868631

Last Updated: 2020-02-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-15

Study Completion Date

2017-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Soy and whey protein have different concentrations of leucine, an amino acid known to be a particularly potent simulator of muscle protein synthesis. The purpose of this study is to determine whether matching soy and whey protein supplements for leucine content instead of by total protein content would contribute to differences in strength increases and muscle growth in response to 12 wk of resistance training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skeletal Muscle Growth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Soy protein group

Group Type ACTIVE_COMPARATOR

Soy protein supplement

Intervention Type DIETARY_SUPPLEMENT

26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.

Whey protein group

Group Type ACTIVE_COMPARATOR

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whey protein supplement

19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.

Intervention Type DIETARY_SUPPLEMENT

Soy protein supplement

26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-smoking
* body mass index (BMI) 18.5-24.9
* recreationally active

Exclusion Criteria

* participated in structured weight training during the previous 12 month
* vegetarian or vegan
* presence of chronic disease
* pregnant, postpartum up to six months, lactating, or intention to become pregnant
* allergy to whey or soy
* changes in body weight more than 10 pounds in the past three months
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Point Loma Nazarene University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Heidi Lynch

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heidi Lynch, PhD

Role: PRINCIPAL_INVESTIGATOR

Point Loma Nazarene University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arizona State University

Phoenix, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01435225

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.